BACKGROUND: Little is known about whether patterns of early growth are associated with altered respiratory and immune development. This study relates prenatal and infant growth patterns to wheeze and atopy at age 3 years. METHODS: Birth weight and length were measured in 1548 children born at term. Conditional fetal head and abdominal circumference growth velocities were calculated from antenatal ultrasound measurements. Conditional postnatal growth velocities were calculated from infant weight, length and adiposity data. Measures of size and conditional growth were related to parentally-reported infant and early childhood wheeze and to atopic status at age 3 years. RESULTS: The risk of atopy increased by 46% per SD increase in abdominal circumference growth velocity from 11 to 19 weeks gestation but by 20% per SD decrease in abdominal growth velocity from 19 to 34 weeks (p=0.007 and p=0.011, respectively). The risk of atopic wheeze increased by 20% per SD decrease in 19-34-week abdominal growth (p=0.046). The risk of non-atopic wheeze increased by 10% per SD decrease in 11-19-week head circumference growth. Greater relative infant weight and adiposity gains were associated with both atopic and non-atopic wheeze. CONCLUSIONS: A rapid growth trajectory during 11-19 weeks gestation followed by late gestation growth faltering is associated with atopy, suggesting that influences affecting fetal growth may also alter immune development. A lower early fetal growth trajectory is associated with non-atopic wheeze, possibly reflecting an association with smaller airways. An association between postnatal adiposity gain and wheeze may partly reflect prenatal influences that cause fetal growth to falter but are then followed by postnatal adiposity gain.
BACKGROUND: Little is known about whether patterns of early growth are associated with altered respiratory and immune development. This study relates prenatal and infant growth patterns to wheeze and atopy at age 3 years. METHODS: Birth weight and length were measured in 1548 children born at term. Conditional fetal head and abdominal circumference growth velocities were calculated from antenatal ultrasound measurements. Conditional postnatal growth velocities were calculated from infant weight, length and adiposity data. Measures of size and conditional growth were related to parentally-reported infant and early childhood wheeze and to atopic status at age 3 years. RESULTS: The risk of atopy increased by 46% per SD increase in abdominal circumference growth velocity from 11 to 19 weeks gestation but by 20% per SD decrease in abdominal growth velocity from 19 to 34 weeks (p=0.007 and p=0.011, respectively). The risk of atopic wheeze increased by 20% per SD decrease in 19-34-week abdominal growth (p=0.046). The risk of non-atopic wheeze increased by 10% per SD decrease in 11-19-week head circumference growth. Greater relative infant weight and adiposity gains were associated with both atopic and non-atopic wheeze. CONCLUSIONS: A rapid growth trajectory during 11-19 weeks gestation followed by late gestation growth faltering is associated with atopy, suggesting that influences affecting fetal growth may also alter immune development. A lower early fetal growth trajectory is associated with non-atopic wheeze, possibly reflecting an association with smaller airways. An association between postnatal adiposity gain and wheeze may partly reflect prenatal influences that cause fetal growth to falter but are then followed by postnatal adiposity gain.
Authors: Jane S Lucas; Hazel M Inskip; Keith M Godfrey; Claire T Foreman; John O Warner; Rachael K Gregson; Joanne B Clough Journal: Am J Respir Crit Care Med Date: 2004-06-01 Impact factor: 21.405
Authors: M I Gunnbjörnsdóttir; E Omenaas; T Gíslason; E Norrman; A C Olin; R Jõgi; E J Jensen; E Lindberg; E Björnsson; K Franklin; C Janson; A Gulsvik; B Laerum; C Svanes; K Torén; A Tunsäter; L Lillienberg; D Gíslason; T Blöndal; U S Björnsdottir; K B Jörundsdóttir; R Talvik; B Forsberg; K Franklin; B Lundbäck; M Söderberg; M C Ledin; G Boman; D Norbäck; G Wieslander; U Spetz-Nyström; K Stenudd Cashelunge; E Rydén Journal: Eur Respir J Date: 2004-07 Impact factor: 16.671
Authors: E M Oliver; K E C Grimshaw; A A Schoemaker; T Keil; D McBride; A B Sprikkelman; H S Ragnarsdottir; V Trendelenburg; E Emmanouil; M Reche; A Fiocchi; A Fiandor; A Stanczyk-Przyluska; J Wilczynski; M Busacca; S T Sigurdardottir; R Dubakiene; O Rudzeviciene; G D Vlaxos; K Beyer; G Roberts Journal: Matern Child Health J Date: 2014-12
Authors: S Hasan Arshad; Wilfried Karmaus; Abid Raza; Ramesh J Kurukulaaratchy; Sharon M Matthews; John W Holloway; Alireza Sadeghnejad; Hongmei Zhang; Graham Roberts; Susan L Ewart Journal: J Allergy Clin Immunol Date: 2012-05-18 Impact factor: 10.793
Authors: Rodney D Britt; Arij Faksh; Elizabeth Vogel; Richard J Martin; Christina M Pabelick; Y S Prakash Journal: Expert Rev Respir Med Date: 2013-10-03 Impact factor: 3.772
Authors: Kenneth Ayuurebobi Ae-Ngibise; Blair J Wylie; Ellen Boamah-Kaali; Darby W Jack; Felix Boakye Oppong; Steven N Chillrud; Stephaney Gyaase; Seyram Kaali; Oscar Agyei; Patrick L Kinney; Mohammed Mujtaba; Rosalind J Wright; Kwaku Poku Asante; Alison G Lee Journal: BMC Pregnancy Childbirth Date: 2019-10-29 Impact factor: 3.007
Authors: Katharine C Pike; Hazel M Inskip; Sian M Robinson; Cyrus Cooper; Keith M Godfrey; Graham Roberts; Jane S A Lucas Journal: Thorax Date: 2013-01-03 Impact factor: 9.139
Authors: Samuel A Collins; Katharine C Pike; Hazel M Inskip; Keith M Godfrey; Graham Roberts; John W Holloway; Jane S A Lucas Journal: Pediatr Pulmonol Date: 2013-02-08
Authors: Emma L Anderson; Abigail Fraser; Richard M Martin; Michael S Kramer; Emily Oken; Rita Patel; Kate Tilling Journal: Pediatr Allergy Immunol Date: 2013-02-03 Impact factor: 6.377